Table 1.
CV risk assessment among biopsy-proven lupus nephritis and ANCA-associated vasculitis
| Characteristics | All, n = 146 |
|---|---|
| Comorbid conditions | |
| Age at diagnosis (years) | 42.6 (32.8–52.6) |
| Male, n (%) | 32 (21.9) |
| Diabetes, n (%) | 12 (8.2) |
| Hypertension, n (%) | 77 (52.7) |
| Systolic blood pressure (mmHg) | 130 (120–140) |
| Diastolic blood pressure (mmHg) | 76 (70–80) |
| Hyperlipidemia, n (%) | 26 (17.8) |
| Ischemic heart disease, n (%) | 4 (2.7) |
| Laboratory tests performed | |
| Hemoglobin A1c, n (%) | |
| aBefore diagnosis | 58 (39.7) |
| cAfter diagnosis | 44 (30.1) |
| Fasting glucose, n (%) | |
| aBefore diagnosis | 118 (80.8) |
| cAfter diagnosis | 131 (89.7) |
| Fasting lipids, n (%) | |
| bBefore diagnosis | 118 (80.8) |
| cAfter diagnosis | 98 (67.1) |
IQRs are the 25th–75th percentile.
a
Performed within 6 months before diagnosis.
b
Performed within 24 months before diagnosis.
c
Performed within 6 months after diagnosis.